| Overall mortality lower with SGLT-2 inhibitors and GLP-1 agonists than with DPP-4 inhibitors
Related items from OnMedica Use of DPP-4 inhibitors associated with increased risk of IBD |
Source: OnMedica
| Overall mortality lower with SGLT-2 inhibitors and GLP-1 agonists than with DPP-4 inhibitors
Related items from OnMedica Use of DPP-4 inhibitors associated with increased risk of IBD |
Source: OnMedica